ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program
July 01, 2021Selexis SA and KBI Biopharma, both JSR Life Sciences companies, have signed service agreements with Immatics N.V., a clinical-stage biopharmaceutical company focused on T cell redirecting cancer immunotherapies. -
Immatics, Roche ally to trial Tecentriq with cell therapy
February 27, 2019Immatics has struck a deal to test its autologous cell therapy in combination with Roche’s checkpoint inhibitor Tecentriq. The clinical collaboration clears Immatics to test whether Roche’s antibody boosts the efficacy of its IMA101 in solid tumors.... -
Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies
July 24, 2018Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced today that it has entered into a research collaboration and license agreement with Ge -
Immatics, Genmab to develop bispecific cancer immunotherapies
July 16, 2018Immatics and Genmab to Combine Proprietary Technologies to Create Transformative Bispecific Therapies against Novel, Proprietary Tumor Targets
Pharma Sources Insight January 2025
